Efficacy of Hot Tea Infusion vs. Ethanolic Extract of Moringa oleifera for the Simultaneous Treatment of Nonalcoholic Fatty Liver, Hyperlipidemia, and Hyperglycemia in a Murine Model Fed with a High-Fat Diet

Table 2

Biochemical and hematic parameters according to the groups studied.

	Parameters	Healthy (n = 11)	NAFLD-placebo (n = 11)	NAFLD-MO ethanolic extract (n = 11)	NAFLD-MO infusion (n = 11)	ANOVA
Biochemical	Cholesterol (mg/dL)	116.9 ± 12.0	181.2 ± 15.0^a	120.1 ± 11.8^d	104.3 ± 11.4^e	<0.001
	Triglycerides (mg/dL)	114.8 ± 15.5	185.5 ± 12.6^a	116.6 ± 15.7^d	93.8 ± 11.2^ef	<0.001
	Total lipids (mg/dL)	156.1 ± 9.6	299.8 ± 15.1^a	199.3 ± 14.1^d	184.3 ± 13.0^e	<0.001
	SGOT (U/L)	184.0 ± 14.2	403.0 ± 12.1^a	210.1 ± 14.3^d	178.1 ± 15.0^ef	<0.001
	SGPT (U/L)	128.9 ± 11.9	241.6 ± 16.3^a	130.8 ± 13.9^d	113.2 ± 7.0^ef	<0.001
	Blood glucose (mg/dL)	88.9 ± 13.8	141.1 ± 20.9^a	109.0 ± 9.2^d	114.1 ± 14.8^e	0.002
	Urea (mg/dL)	11.9 ± 5.3	15.4 ± 5.8	12.8 ± 2.8	11.7 ± 5.1	0.525
Hematic	Hemoglobin (g/dL)	12.5 ± 1.1	14.3 ± 0.5^a	14.18 ± 0.2	14.2 ± 0.7^c	<0.001
	Hematocrit (%)	35.6 ± 4.1	39.7 ± 1.5	37.77 ± 0.1	40.0 ± 0.74	0.902
	Platelets (10^∧3/μL)	1207.2 ± 38.1	1210.8 ± 48.8	1008.7 ± 54.1	1127.1 ± 31.5	0.575
	Leukocytes (10^∧9/μL	6.4 ± 2.0	6.4 ± 2.1	6.4 ± 1.6	6.45 ± 0.6	0.262
	Erythrocytes (10^∧12/μL)	8.1 ± 1.0	7.7 ± 0.9	7.6 ± 0.2	7.80 ± 0.3	0.675

All values are expressed as mean ± SEM; the differences of Tukey’s post hoc analysis are marked when they are significant: ^a, healthy vs. NAFLD-placebo, ^b, healthy vs. NAFLD-MO ethanolic extract, ^c, healthy vs. NAFLD-MO infusion, ^d, NAFLD-placebo vs. NAFLD-MO ethanolic extract, ^e, NAFLD-placebo vs. NAFLD-MO infusion, and ^f, NAFLD-MO ethanolic extract vs. NAFLD-MO infusion (n = 11 per group).